Filing Details
- Accession Number:
- 0001054833-11-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-23 14:03:31
- Reporting Period:
- 2011-12-22
- Filing Date:
- 2011-12-23
- Accepted Time:
- 2011-12-23 14:03:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1054833 | Coventry Health Care Inc | CVH | Hospital & Medical Service Plans (6324) | 522073000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234091 | C Thomas Zielinski | 6705 Rockledge Drive, Suite 900 Bethesda MD 20817 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-12-22 | 66,667 | $18.07 | 150,253 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-12-22 | 66,667 | $31.14 | 83,586 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2011-12-22 | 20,000 | $20.46 | 103,586 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-12-22 | 20,000 | $31.14 | 83,586 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option | Acquisiton | 2011-12-22 | 66,667 | $0.00 | 66,667 | $18.07 |
Common Stock | Non-Qualified Stock Option | Disposition | 2011-12-22 | 314,236 | $0.00 | 20,000 | $20.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
334,236 | 2010-06-22 | 2019-06-22 | No | 4 | M | Direct |
314,236 | 2011-05-26 | 2020-05-26 | No | 4 | M | Direct |
Footnotes
- Includes the following: Table I - Non-Derivative Securities consisting of 66,667 shares of common stock held directly pursuant to the exercise of a non-qualified stock option, 3,785 shares of common stock held indirectly by managed account (401(k) Plan), and 79,801 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over four-year periods.
- See Footnote 1 for shares held directly and indirectly.
- Includes the following: Table I - Non-Derivative Securities consisting of 3,785 shares of common stock held indirectly by managed account (401(k) Plan), and 79,801 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over four-year periods.
- See Footnote 3 for shares held directly and indirectly.
- Includes the following: Table I - Non-Derivative Securities consisting of 20,000 shares of common stock held directly pursuant to the exercise of a non-qualified stock option, 3,785 shares of common stock held indirectly by managed account (401(k) Plan), and 79,801 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over four-year periods.
- See Footnote 5 for shares held directly and indirectly.
- Includes the following: Table I - Non-Derivative Securities consisting of 3,785 shares of common stock held indirectly by managed account (401(k) Plan), and 79,801 shares of restricted common stock with restrictions lapsed or lapsing in equal annual increments over four-year periods.
- See Footnote 7 for shares held directly and indirectly.
- Exercisable in equal annual increments with the first increment exercisable on 6/22/2010.
- Includes the following: Table II-Derivative Securities consisting of non-qualified stock options for 334,236 shares of common stock vested or vesting in equal annual increments over three- and four-year periods, held directly; and 50,000 performance stock units that will be settled in cash if the award vests.
- Includes the following: Table II-Derivative Securities consisting of non-qualified stock options for 314,236 shares of common stock vested or vesting in equal annual increments over three- and four-year periods, held directly; and 50,000 performance stock units that will be settled in cash if the award vests.